BioNTech SE - ADR

NASDAQ:BNTX  
247.69
-2.64 (-1.06%)
Products

Pfizer-Biontech Covid-19 Vaccine Comirnaty Receives Full Health Canada Approval For Individuals 12 Years And Older

Published: 09/16/2021 16:29 GMT
BioNTech SE - ADR (BNTX) - Pfizer-biontech Covid-19 Vaccine Comirnaty® Receives Full Health Canada Approval for Individuals 12 Years and Older.
Pfizer Canada - Health Canada Has Granted Full Approval for Comirnaty to Prevent Covid-19 in Individuals 12 Years of Age and Older.
Pfizer Canada - Vaccine's Brand Name Will Be Comirnaty Following Approval.
Pfizer Canada - Canada Will Continue to Receive Vials of Vaccine Labeled As Pfizer-biontech Covid-19 Vaccine.
Pfizer Canada - Gradual Transition to New Labeling With Comirnaty Brand Name Will Occur at a Later Date.